documents: FDA-2012-D-0307-0037
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-D-0307-0037 | FDA | FDA-2012-D-0307 | Reference 26- Development of Dose-Response Models of Creutzfeldt-Jakob Disease Infection in Nonhuman Primates re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability | Supporting & Related Material | Background Material | 2020-02-25T05:00:00Z | 2020 | 2 | 2020-02-25T16:03:56Z | 0 | 0 | 09000064843ae6d8 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref